CIK 0001919246
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 863335449
- Phone
- +1 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,939
- in 3 filings, $45K under 10b5-1 plans
Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Davis Todd C Director | Purchase | +35,445 | $27.80 | $986K | 75,331 |
| 2026-06-11 | Davis Todd C Director | Purchase | +503 | $28.73 | $14K | 75,834 |
| 2025-07-02 | Davis Todd C Director | Grant or award | +19,108 | 39,886 | ||
| 2025-07-02 | Davis Todd C Director | Grant or award · Restricted Stock Units | +19,108 | 36,969 | ||
| 2025-07-02 | Davis Todd C Director | Grant or award · Stock Option | +58,230 | 58,230 | ||
| 2025-07-01 | Davis Todd C Director | Conversion | +1,500,000 | $10.00 | $15.0M | 1,500,000 |
| 2025-07-01 | Davis Todd C Director | Conversion · Series A Convertible Preferred Stock | −15,000 | 3,000 | ||
| 2025-07-01 | Davis Todd C Director | Other acquisition · Series A Convertible Preferred Stock | +31,278.68 | 3,127,868 | ||
| 2024-11-13 | Davis Todd C Director | Grant or award | +4,961 | 20,778 | ||
| 2024-11-13 | Davis Todd C Director | Grant or award · Restricted Stock Units | +49,605 | 263,306 | ||
| 2024-06-14 | Davis Todd C Director | Grant or award | +12,900 | 15,817 | ||
| 2024-06-14 | Davis Todd C Director | Grant or award · Restricted Stock Units | +128,977 | 213,701 | ||
| 2024-02-21 | Davis Todd C Director | Exercise or conversion | +29,167 | $4.80 | $140K | 29,167 |
| 2024-02-21 | Davis Todd C Director | Conversion · Secured Convertible Promissory Note | −0 | 0 |
Page 1 of 1 · 14 trades